TTK Healthcare share news, announcements and annual reports
NSE: TTKHLTCAREBSE: 507747DiversifiedSmall Cap
TTK Healthcare Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1987 on BSE, Jul 2010 on NSE
Last close ₹905.30down ₹143.80 (13.71%)BSE ₹905.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,049.10.
30 Oct: open ₹1,043.70, high ₹1,144.90, low ₹884.00
52-week range of traded prices to 30 Oct 2026
₹735.00Low, 30 Mar 2026₹1,247.00High, 9 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,279 Cr1,358th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 4.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹244 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 39.46
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.95
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.10%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 22.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹244 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 2.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,25,83516.4% delivered
TTK Healthcare board meetings
96 filed, newest first. Page 2 of 2.
Aug 2020
4 Aug · Board meeting
Jul 2020
Jan 2020
28 Jan · Board meeting
9 Jan · Board meeting
Oct 2019
15 Oct · Board meeting
Aug 2019
12 Aug · Board meeting
Jun 2019
29 Jun · Board meeting
May 2019
30 May · Board meeting
Jan 2019
9 Jan · Board meeting
Oct 2018
Jul 2018
11 Jul · Board meeting
May 2018
Jan 2018
Oct 2017
Jul 2017
May 2017
Jan 2017
Oct 2016
Jul 2016
May 2016
Apr 2016
Jan 2016
Oct 2014
17 Oct · Board meeting
Iner alia, to consider and approve the unaudited financial results for the second quarter ended 30th September 2014 (Source MSE)
Aug 2014
25 Aug · Board meeting
Board of Directors, in their meeting held on 22nd August 2014, confirmed the appointment of the existing managerial personnel as follows: (1) Mr. T. T. Raghunathan, Executivd Vice Chairman as the Chief Executive Officer (CEO) (2) Mr. S. Kalyanaraman, President - Commercial & Company Secretary as Company Secretary; and (3) Mr. B V K Durga Prasad, Senior Vice President - Finance as Chief Financial Officer (CFO) as Key Managerial Personnel of the Company in accordance with the provisions of section 203 of the Companies Act 2013 and the Rules made thereunder. (Source MSE)
Jul 2014
18 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results for the first quarter ended 30th June 2014 (Source MSE)
Apr 2014
28 Apr · Board meeting
Inter alia , to consider and approve the Audited Financial Results of the Company for the year ended 31st March 2014. (Source MSE)
Jan 2014
16 Jan · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third Quarter ended 31st December 2013. (Source MSE)
Oct 2013
7 Oct · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the Second Quarter ended 30th September 2013. (Source MSE)
Jul 2013
15 Jul · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the first quarter ended 30th June 2013. (Source MSE)
May 2013
15 May · Board meeting
Inter-alia, to consider and approve the Audited Financial Results of the Company for the year ended 31st March 2013 and recommendation of dividend, if any. (Source MSE)
Apr 2013
Jan 2013
10 Jan · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the Third Quarter ended 31st December 2012. (Source MSE)
Oct 2012
9 Oct · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the Second Quarter ended 30th September 2012. (Source MSE)
Jul 2012
31 Jul · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the first quarter ended 30th June 2012. (Source MSE)
Apr 2012
20 Apr · Board meeting
Inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended 31st March 2012 and recommendation of dividend, if any. (Source MSE)
Jan 2012
20 Jan · Board meeting
To consider and approve the Un-audited Financial Results of the Company for the Third Quarter ended 31st December, 2011 (Source MSE)
Oct 2011
24 Oct · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the Second quarter ended 30th September, 2011. (Source MSE)
Jul 2011
1 Jul · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended 30th June, 2011. (Source MSE)
Apr 2011
28 Apr · Board meeting
Inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended 31st March, 2011 and recommendation of dividend, if any. (Source MSE)
Jan 2011
14 Jan · Board meeting
To consider and approve the Unaudited Financial results of the Company for the Third Quarter ended 31st December, 2010. (Source MSE)
Oct 2010
22 Oct · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results for the second quarter ended 30th September 2010 (Source MSE)
Jul 2010
13 Jul · Board meeting
To consider and approve the Un-audited Financial Results (Provisional) of the Company for the First Quarter ended 30th June 2010 (Source MSE)
May 2010
20 May · Board meeting
Highlights of Audited Financial Results of the Company for the year ended 31st March 2010 approved by the Board of Directors at their meeting held on 20th May 2010. Attachment follows (Source MSE)
Apr 2010
27 Apr · Board meeting
To consider and approve the Audited Financial Results of the Company for the financial year ended 31st Mach 2010 and recommendation of dividend, if any. (Source MSE)